Regarding the editorial by Sau and Ng. 'Hypertrophic cardiomyopathy risk stratification based on clinical or dynamic electrophysiological features: two sides of the same coin'.
作者信息
Saumarez Richard, Silberbauer John, Scannell Jack, Pytkowski Mariusz, Peters Nicolas
机构信息
Waterbeach CB25 9HW, UK.
Department Cardiology, Royal Sussex Hospital, Eastern Road, Brighton BN2 5BEUK.
出版信息
Europace. 2023 Jul 4;25(7). doi: 10.1093/europace/euad175.
Abstract
摘要
相似文献
1
Regarding the editorial by Sau and Ng. 'Hypertrophic cardiomyopathy risk stratification based on clinical or dynamic electrophysiological features: two sides of the same coin'.
Europace. 2023 Jul 4;25(7). doi: 10.1093/europace/euad175.
2
Response to letter by Saumarez et al. entitled 'Regarding the editorial by Sau and Ng. "Hypertrophic cardiomyopathy risk stratification based on clinical or dynamic electrophysiological features: two sides of the same coin"'.
Europace. 2023 Jul 4;25(7). doi: 10.1093/europace/euad174.
3
Hypertrophic cardiomyopathy risk stratification based on clinical or dynamic electrophysiological features: two sides of the same coin.
Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad072.
4
[Risk stratification in hypertrophic cardiomyopathy].
Rev Med Liege. 2009 Nov;64(11):576-80.
5
Apical hypertrophic cardiomyopathy--a benign condition?
J Insur Med. 2014;44(2):118-21.
6
Delayed hyperenhancement magnetic resonance imaging for sudden cardiac death risk stratification in hypertrophic cardiomyopathy.
J Am Coll Cardiol. 2009 Dec 29;55(1):77. doi: 10.1016/j.jacc.2008.09.068.
7
Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry.
Lancet. 2013 Dec 7;382(9908):1889-97. doi: 10.1016/S0140-6736(13)61685-2. Epub 2013 Sep 3.
8
Arrhythmic risk stratification in hypertrophic cardiomyopathy: are we missing something?
Europace. 2021 Apr 6;23(4):648-649. doi: 10.1093/europace/euaa317.
9
Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy.
Congenit Heart Dis. 2014 Mar-Apr;9(2):E51-7. doi: 10.1111/chd.12073. Epub 2013 May 7.
10
Are all non-sustained ventricular tachycardia the same in hypertrophic cardiomyopathy risk stratification for sudden cardiac death?
J Cardiovasc Electrophysiol. 2020 Aug;31(8):2099-2100. doi: 10.1111/jce.14573. Epub 2020 May 27.
本文引用的文献
1
Hypertrophic cardiomyopathy risk stratification based on clinical or dynamic electrophysiological features: two sides of the same coin.
Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad072.
2
Should lethal arrhythmias in hypertrophic cardiomyopathy be predicted using non-electrophysiological methods?
Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad045.
3
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM).
Circulation. 2018 Mar 6;137(10):1015-1023. doi: 10.1161/CIRCULATIONAHA.117.030437. Epub 2017 Nov 30.
4
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).
Eur Heart J. 2014 Aug 7;35(30):2010-20. doi: 10.1093/eurheartj/eht439. Epub 2013 Oct 14.
Zotero 插件